Literature DB >> 20631107

Genogroup IIb norovirus infections and association with enteric symptoms in a neonatal nursery in southern India.

Vipin Kumar Menon1, Santosh George, Sasirekha Ramani, Jeyaram Illiayaraja, Rajiv Sarkar, Atanu Kumar Jana, Kurien Anil Kuruvilla, Gagandeep Kang.   

Abstract

Noroviruses (NoVs) are increasingly recognized as an important cause of acute gastroenteritis in children worldwide. However, there are limited data on the role of NoVs in neonatal infections and disease. The objectives of the present study were to determine the prevalence of NoVs in neonates with gastrointestinal disease using a case-control study design and to characterize the NoV strains infecting neonates. A total of 309 fecal samples from 161 neonates with gastrointestinal symptoms and 148 asymptomatic controls were screened for genogroup II (GII) NoV using reverse transcription-PCR. A subset of PCR-positive amplicons for the polymerase and capsid regions was sequenced. NoV was detected in 26.2% of samples, with the rate of detection being significantly higher among symptomatic neonates (60/161, 37.2%) than asymptomatic neonates (24/148, 14.1%) (P < 0.001). On the basis of sequencing of 29 strains, a single NoV strain, GIIb, was identified to be the predominant (27/29, 93.1%) cause of neonatal infections. Coinfection with rotavirus was seen in nearly one-third of symptomatic neonates. The study demonstrates a high prevalence of NoV infections in neonates and indicates that coinfection with rotavirus may result in significantly more gastrointestinal disease in this population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20631107      PMCID: PMC2937701          DOI: 10.1128/JCM.02510-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Genotyping of GII.4 and GIIb norovirus RT-PCR amplicons by RFLP analysis.

Authors:  Stefania Ramirez; Giovanni M Giammanco; Simona De Grazia; Claudia Colomba; Vito Martella; Serenella Arista
Journal:  J Virol Methods       Date:  2007-10-22       Impact factor: 2.014

3.  Norovirus in a Dutch tertiary care hospital (2002-2007): frequent nosocomial transmission and dominance of GIIb strains in young children.

Authors:  M F C Beersma; M Schutten; H Vennema; N G Hartwig; T H M Mes; A D M E Osterhaus; G J J van Doornum; M Koopmans
Journal:  J Hosp Infect       Date:  2009-01-14       Impact factor: 3.926

4.  Molecular epidemiology of norovirus gastroenteritis investigated using samples collected from children in Tunisia during a four-year period: detection of the norovirus variant GGII.4 Hunter as early as January 2003.

Authors:  Khira Sdiri-Loulizi; Katia Ambert-Balay; Hakima Gharbi-Khelifi; Nabil Sakly; Mouna Hassine; Slaheddine Chouchane; Mohamed Neji Guediche; Pierre Pothier; Mahjoub Aouni
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

5.  Epidemiological, clinical, and molecular features of norovirus infections in western India.

Authors:  Preeti Chhabra; Ramchandra K Dhongade; Vijay R Kalrao; Ashish R Bavdekar; Shobha D Chitambar
Journal:  J Med Virol       Date:  2009-05       Impact factor: 2.327

6.  Rotavirus infection in the neonatal nurseries of a tertiary care hospital in India.

Authors:  Sasirekha Ramani; Thuppal V Sowmyanarayanan; Beryl Primrose Gladstone; Kaushik Bhowmick; Jaya Ruth Asirvatham; Atanu Kumar Jana; Kurien Anil Kuruvilla; Manish Kumar; Sridhar Gibikote; Gagandeep Kang
Journal:  Pediatr Infect Dis J       Date:  2008-08       Impact factor: 2.129

7.  Sequential evolution of genotype GII.4 norovirus variants causing gastroenteritis outbreaks from 2001 to 2006 in Eastern Spain.

Authors:  Javier Buesa; Rebeca Montava; Reem Abu-Mallouh; Marta Fos; Juan M Ribes; Rosa Bartolomé; Herme Vanaclocha; Núria Torner; Angela Domínguez
Journal:  J Med Virol       Date:  2008-07       Impact factor: 2.327

8.  Norovirus infections in preterm infants: wide variety of clinical courses.

Authors:  Sven Armbrust; Axel Kramer; Dirk Olbertz; Kathrin Zimmermann; Christoph Fusch
Journal:  BMC Res Notes       Date:  2009-06-02

9.  Analysis of amino acid variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-specific epitopes.

Authors:  David J Allen; Jim J Gray; Chris I Gallimore; Jacqueline Xerry; Miren Iturriza-Gómara
Journal:  PLoS One       Date:  2008-01-23       Impact factor: 3.240

10.  Outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit.

Authors:  Reina M Turcios-Ruiz; Peter Axelrod; Keith St John; Esther Bullitt; Joan Donahue; Nancy Robinson; Helena E Friss
Journal:  J Pediatr       Date:  2008-06-05       Impact factor: 4.406

View more
  4 in total

1.  Prevalence of rotavirus, norovirus and enterovirus in diarrheal diseases in Himachal Pradesh, India.

Authors:  Swapnil Jain; Nutan Thakur; Neelam Grover; Jitendraa Vashistt; Harish Changotra
Journal:  Virusdisease       Date:  2016-02-03

2.  Absence of genetic differences among G10P[11] rotaviruses associated with asymptomatic and symptomatic neonatal infections in Vellore, India.

Authors:  Margaret H Libonati; Allison F Dennis; Sasirekha Ramani; Sarah M McDonald; Asmik Akopov; Ewen F Kirkness; Gagandeep Kang; John T Patton
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

3.  Astroviruses in rabbits.

Authors:  Vito Martella; Paschalina Moschidou; Pierfrancesco Pinto; Cristiana Catella; Constantina Desario; Vittorio Larocca; Elena Circella; Krisztian Bànyai; Antonio Lavazza; Chiara Magistrali; Nicola Decaro; Canio Buonavoglia
Journal:  Emerg Infect Dis       Date:  2011-12       Impact factor: 6.883

Review 4.  Norovirus Infections and Disease in Lower-MiddleandLow-Income Countries, 1997⁻2018.

Authors:  Janet Mans
Journal:  Viruses       Date:  2019-04-10       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.